Table 1

 Demographic features

Phase 1, entire group (n = 687)Phase II
Combination group (n = 56)SASP alone (n = 55)MTX alone (n = 54)
BMI, body mass index; DAS, disease activity score; MTX, methotrexate; RF, rheumatoid factor; SASP, sulfasalazine.
The values are represented as median (range).
Overall 70% of patients had a disease duration of ⩽1 year, 22% >1–5 years, and 8% 6–10 years.
Age (years)55 (18–80)56 (30–78)55 (18–77)53 (34–79)
Disease duration (years)1.0 (1–10)1.0 (1–9)1.0 (1–7)1.0 (1–9)
    Mean1.81.91.61.8
Female (%)77757579
Smokers (%)42463758
RF positive (%)65686465
BMI28 (16–58)28 (21–58)28 (18–40)29 (16–44)
DAS4.0 (2.4–7.8)3.63 (2.4–5.3)3.67 (2.5–5.4)3.5 (2.4–5.9)
Total Sharp score17.0 (0–149)14.0 (0–92)12.0 (0–195)